| Drug class | Outcomes | Illustrative comparative risks (95% CI) | Relative effect (95% CI) |
Number of participants (studies) |
Quality of the evidence (GRADE) | Comment | |
| Intervention + usual care | Usual care alone | ||||||
| Recurrent stroke | |||||||
| Cardiovascular event | |||||||
| Infections | |||||||
| SAEs* | |||||||
| Cardiovascular death | |||||||
| All cause death | |||||||